Trial NCT04065841

View at ClinicalTrials.gov 
Org. Study IDs: CLJN452D12201C
Secondary IDs: 2019-002324-32

Last trial update was posted on 2023-12-26

MeSH Interventions

Licogliflozin

MeSH Conditions

Fatty Liver Liver Cirrhosis Non-alcoholic Fatty Liver Disease

Other Conditions

Non Alcoholic Steatohepatitis (NASH)

Stopping Reasons

The sponsor made a business decision to stop development of the trial drugs. The decision to stop the trial early was not because of any safety concerns.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID